Daily Equity Reports 12 April 2019

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 12 THAPRIL 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! INDIANEQUITYBENCHMARK- Benchmarkindicesended flat after a rangebound session on April 11 as traders remainedcautiousaheadofTCS&Infosysearnings NIFTY scheduled to be announced tomorrow. The 30-share BSE CLOSE PREVIOUS Sensex rose 21.66 points to 38,607.01 and the Nifty50 NIKKEI gained 12.40 points at 11,596.70. The market breadth remainedinfavourofbearsasabout1,325sharesdeclined against 1,153 advancing shares on the BSE. Indiabulls 2224.44 2224.39 HousingFinance,BajajFinserv,BhartiAirtel,BajajAutoand SECTORIAL INDICES DrReddy'sLabsweregainerswhileInfosys,TCS,Vedanta, CLOSE CHANGE (%) SunPharma,PowerGrid,TechMahindrawerelosersamong CNX 100 0.14 Nifty50 stocks. Manappuram Finance, HDFC Life, ICICI S&P CNX 500 9634.55 0.12 Prudential, Rain Industries, CG Power, Tata Global, Adani PowerandTataPowerweremidcapgainerswhileReliance 5030.70 Naval,EdelweissFinancial,JubilantFoodworksandDLFlost CNX 200 6060.25 0.13 2-7percent. GLOBALFACE BANK NIFTY TOP GAINERS ! CLOSE CHANGE (%) AsianMarket- Asianmarketsfinishedmixedasofthemost recentclosingprices.TheNikkei225gained0.11%,whilethe ShanghaiCompositeledtheHangSenglower.Theyfell1.60% 2.54 BHARTIARTL 2.00 and0.93%respectively. BAJAJFINSV 1.84 ! BAJAJ-AUTO 1.67 U.S.Market– NorthandSouthAmericanmarketsfinished mixedas ofthemostrecentclosingprices.TheS&P500 TOP LOSERS gained0.35%,whiletheIPCledtheBovespalower.Theyfell 0.54%and0.35%respectively. CLOSE CHANGE (%) ! European markets – European markets are higher today with sharesinFranceleadingtheregion.TheCAC40isup SUNPHARMA 0.53%whileGermany'sDAXisup0.13%andLondon'sFTSE 100isup0.04%. TECHM Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND STRATEGY BUY ON DIPS SCRIPT CLOSE (%) 2.54 PIVOT POINTS 1.56 S3 11472 S2 11528 R1 11618 R2 11640 R3 11696 11562 11584 1.48 GAIL S1-11471 S2-11353 R1-11715 R2-11820 1.45 CLOSE (%) -3.79 VEDL -1.26 AXISBANK INFY -1.24 -1.24 TATASTEEL NET BUY (CR.) NET STRATEGY BUY ON DIPS SELL (CR) BULLISH PIVOT POINTS P 29912 6433.94 S1 29815 R1 30052 R2 R3 30386 29438 29675 30149 RESISTANCE DII 3174.13 BANK NIFTY NSE TOTALS ADVANCE S NIFTY BANK NIFTY 9 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! Vedantaslips3%afterreportsof!LupingetsFDAapprovalfor Zambianvillagerstosuecompany Shares of Vedanta were trading 3% down on Thursday aftermediareportsstatedthattheSupremeCourtinthe UKhasruledthatZambianvillagerscansuethecompany inBritishcourtsoverallegedpollutionbyacopperminein thecountry.Asperreports,thecompany,whichdelisted from London exchanges last year but maintains a legal baseinBritain,pleadedalower-courtrulingthatacase couldbeheardinEngland.However,SCdismisseditsplea and said the Zambian villagers could pursue their case throughtheEnglishcourts. TestosteroneGel PharmamajorLupinLimited(Lupin)announcedthatit has received approval for its Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), from the United StatesFoodandDrugAdministration(FDA)tomarketa generic version of AbbVie, Incs (AbbVie) AndroGel 1.62%.LupinsTestosteroneGel,1.62%(20.25mg/1.25g pump actuation), is the generic equivalent of AbbVies AndroGel,1.62%.Itisindicatedforreplacementtherapy inmalesforconditionsassociatedwithadeficiencyor absence of endogenous hypogonadism (congenital Hypogonadotropic hypogonadism acquired) Testosterone Gel, 1.62% (20.25 mg/1.25 g pumpactuation), (RLD: AndroGel) had annual sales of approximately$893mnintheUS(IQVIAMATDecember 2018). testosterone: or Primary ! acquired) (congenital and or Cox&KingsFinancialServicesslipsafter listingonstockexchanges Shares of Cox & Kings Financial Services (CKFS), the demerged entity from Cox & Kings, listed on the stock exchangestoday.Thecompanysboardhadapprovedthe de-merger of the foreign exchange business into a separate financial services company. One fully paid-up equitysharesofRs10eachofCKFSwascreditedforevery threefullypaid-upequitysharesofRs5eachheldbyits shareholders,whosenameshadappearedontherecord booksasonOctober28,2018. ! WockhardtgetsUSFDAnodforDecitabine injection SharesofWockhardtgained2%onWednesdayafterthe companyinitsfilingtotheexchangesinformedthatithas receivedapprovalfromtheUnitedStatesFood&Drug Administration(USFDA)foranANDAfor50mginjectionof DecitabinemarketedintheUSandothercountriesbyOtsuka. DecitabineisusedtotreatMyelodysplasticsyndromes(MDS),a groupofcancersinwhichimmaturebloodcellsinthebone marrowdonotmatureandthereforedonotbecomehealthy bloodcells,thecompanysaidinapressnoteaftermarketshours totheexchangesonWednesday.AccordingtoIQVIAFebruary 2019data,theproducthassalesof$120mntheUS. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NAME OF THE STOCK : ASHOKLEY DATE : 12/04/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENTADVICE: CALLCS CALL:- BUY ASHOKLEY IN CASH ABOVE 94.50 TGT 97 SL 93 RATIONALEFORARRIVINGINVESTMENTADVICE: TECHNICALVIEW: THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE BRANCH OFFICE Capitalstars Financial Research Private Limited Capitalstars Financial Research Private Limited PLOT NO.32,MECHANICNAGAREXTENSION,IDASCHEME NO.54,VIJAYNAGARINDORE REGISTERED OFFICE REGISTERED OFFICE PLOT NO.12,SCHEMENO.78PART-2,VIJAYNAGAR,INDORE Email:-backoffice@capiltalstars.in Contactus :- 9977499927,9039012727 Report Is Checked by Investment Advisor: Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.